New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
09:20 EDTELGXEndologix announces U.S. VELA Proximal Endograft System launch
Endologix announced the U.S. launch of its new VELA Proximal Endograft System. The VELA Proximal Endograft is specifically designed for the treatment of proximal aortic neck anatomies during an endovascular aneurysm repair procedure using the Endologix AFX Endovascular AAA System. The doctor who performed the procedure said, "The VELA delivery system is very intuitive and the endograft has excellent visibility. Our early experience has been very positive and we are planning to use the VELA Proximal Endograft in a live EVAR procedure on February 12 at the iCON meeting in Phoenix, Arizona."
News For ELGX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 12, 2015
09:08 EDTELGXEndologix announces FDA approval of AFX 2
Subscribe for More Information
October 9, 2015
08:48 EDTELGXInvestors should look at several medtech stocks, says BMO Capital
BMO Capital believes that macro issues have caused declines in medtech stocks. However, the firm thinks that the sector dealt with pricing issues years ago, while patient volumes are rising and larger cap names in the sector have "relatively stable revenue streams." BMO recommends that investors look at stocks with "reasonable multiples," such as Medtronic (MDT), those with new product pipelines such as Boston Scientific (BSX) and Edwards Lifesciences (EW), and those with small-cap product cycles, including Nevro (NVRO), NuVasive (NUVA), and Endologix (ELGX).
October 7, 2015
08:17 EDTELGXEndologix a stock to own into 2016, says JPMorgan
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use